Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported ...

Enter NEO, a humanoid robot created by 1X, an artificial intelligence and robotics company based in Palo Alto, California.

NeoGenomics (NEO) has seen its stock make some sizable moves over the past month, gaining 32% despite a more muted performance year to date. Investors appear to be reacting to a shifting outlook as ...

NeoGenomics (NEO) is still running at a loss, with losses having increased by 30% per year over the past five years and no notable rebound in profit margins. Revenue is expected to grow at 8.7% per ...